Long-term impact of fecal transplantation in healthy volunteers
Visualitza/Obre
Cita com:
hdl:2117/181462
Tipus de documentArticle
Data publicació2019-12
Condicions d'accésAccés obert
Llevat que s'hi indiqui el contrari, els
continguts d'aquesta obra estan subjectes a la llicència de Creative Commons
:
Reconeixement 3.0 Espanya
Abstract
Fecal microbiota transplantation (FMT) has been recently approved by FDA for the treatment of refractory recurrent clostridial colitis (rCDI). Success of FTM in treatment of rCDI led to a number of studies investigating the effectiveness of its application in the other gastrointestinal diseases. However, in the majority of studies the effects of FMT were evaluated on the patients with initially altered microbiota. The aim of our study was to estimate effects of FMT on the gut microbiota composition in healthy volunteers and to monitor its long-term outcomes.
CitacióGoloshchapov, O. [et al.]. Long-term impact of fecal transplantation in healthy volunteers. "BMC microbiology", Desembre 2019, vol. 19, p. 312:1-312:13.
ISSN1471-2180
Col·leccions
Fitxers | Descripció | Mida | Format | Visualitza |
---|---|---|---|---|
27020096.pdf | 1,095Mb | Visualitza/Obre |